These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 32350570)

  • 21. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model.
    Zhang W; Ba G; Tang R; Li M; Lin H
    Int Immunopharmacol; 2020 Jun; 83():106394. PubMed ID: 32193102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-patchoulene alleviates cognitive dysfunction in a mouse model of sepsis associated encephalopathy by inhibition of microglia activation through Sirt1/Nrf2 signaling pathway.
    Tian Y; Wang L; Fan X; Zhang H; Dong Z; Tao T
    PLoS One; 2023; 18(1):e0279964. PubMed ID: 36608000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol Protects against Sepsis-Associated Encephalopathy and Inhibits the NLRP3/IL-1β Axis in Microglia.
    Sui DM; Xie Q; Yi WJ; Gupta S; Yu XY; Li JB; Wang J; Wang JF; Deng XM
    Mediators Inflamm; 2016; 2016():1045657. PubMed ID: 26924896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen-rich saline regulates NLRP3 inflammasome activation in sepsis-associated encephalopathy rat model.
    Dumbuya JS; Chen X; Du J; Li S; Liang L; Xie H; Zeng Q
    Int Immunopharmacol; 2023 Oct; 123():110758. PubMed ID: 37556997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization.
    Yang X; Sun A; Kong L; Yang X; Zhao X; Wang S
    Int Immunopharmacol; 2024 Aug; 137():112374. PubMed ID: 38851162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
    Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
    J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
    Qu J; Yuan Z; Wang G; Wang X; Li K
    Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of P2X
    Zhang Y; Xu Y; Sun Q; Xue S; Guan H; Ji M
    Exp Eye Res; 2019 Nov; 188():107771. PubMed ID: 31445901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of NLRP3 inhibitor MCC950 on sepsis-induced myocardial dysfunction.
    Li S; Guo Z; Zhang ZY
    J Biol Regul Homeost Agents; 2021; 35(1):141-150. PubMed ID: 33550789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.
    Arioz BI; Tastan B; Tarakcioglu E; Tufekci KU; Olcum M; Ersoy N; Bagriyanik A; Genc K; Genc S
    Front Immunol; 2019; 10():1511. PubMed ID: 31327964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
    Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
    Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
    Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
    Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alleviation of sepsis-associated encephalopathy by ginsenoside via inhibition of oxidative stress and cell apoptosis: An experimental study.
    Mei X; Feng H; Shao B
    Pak J Pharm Sci; 2020 Nov; 33(6):2567-2577. PubMed ID: 33867332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture.
    Cornelius DC; Travis OK; Tramel RW; Borges-Rodriguez M; Baik CH; Greer M; Giachelli CA; Tardo GA; Williams JM
    PLoS One; 2020; 15(6):e0234039. PubMed ID: 32555710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrogen gas reduces HMGB1 release in lung tissues of septic mice in an Nrf2/HO-1-dependent pathway.
    Yu Y; Yang Y; Yang M; Wang C; Xie K; Yu Y
    Int Immunopharmacol; 2019 Apr; 69():11-18. PubMed ID: 30660872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. iTRAQ-Based Quantitative Proteomics Indicated Nrf2/OPTN-Mediated Mitophagy Inhibits NLRP3 Inflammasome Activation after Intracerebral Hemorrhage.
    Cheng Y; Liu M; Tang H; Chen B; Yang G; Zhao W; Cai Y; Shang H
    Oxid Med Cell Longev; 2021; 2021():6630281. PubMed ID: 33628368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.
    Primiano MJ; Lefker BA; Bowman MR; Bree AG; Hubeau C; Bonin PD; Mangan M; Dower K; Monks BG; Cushing L; Wang S; Guzova J; Jiao A; Lin LL; Latz E; Hepworth D; Hall JP
    J Immunol; 2016 Sep; 197(6):2421-33. PubMed ID: 27521339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.
    Yaw ACK; Chan EWL; Yap JKY; Mai CW
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
    Luo Y; Lu J; Ruan W; Guo X; Chen S
    Brain Res Bull; 2019 Mar; 146():320-326. PubMed ID: 30716395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.